Believed to be first clinical test to identify variants of four enzymes that mediate drug metabolism, providing greater insights for guiding treatment for the more than 100 million Americans with chronic pain.
Read More
The companies will educate private payors and health plans about the benefits of next-generation sequencing.
Read More
Warfarin, Plavix sensitivity tests, and thrombophilia risk test provide personalized risk assessment, diagnosis, and treatment.
Read More
Test identifies diagnostic biomarkers.
Read MoreThe company’s clinical services lab uses next-generation DNA and genetic analysis technologies that include multiplex real-time PCR, whole genome mapping, and next-generation sequencing.
Read More